ACM
DNA icon

Aquatic Capital Management’s Ginkgo Bioworks DNA Stock Holding History

Aquatic Capital Management’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$47.8K Buy
4,828
+3,002
+164% +$25.1K ﹤0.01% 1155
2026
Q1 		$11.2K Buy
+1,826
New +$15.2K ﹤0.01% 1267
2025
Q2 		– Sell
-146
Closed -$832 – 1301
2025
Q1 		$832 Buy
+146
New +$1.49K ﹤0.01% 1212

Other funds holding DNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

Aquatic Capital Management's DNA Position: Q2 2026 in Review

Aquatic Capital Management increased its Ginkgo Bioworks (DNA) stake by 164% in Q2 2026, buying an estimated $25.1K and bringing the position to 4,828 shares worth $47.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1155.

Aquatic Capital Management first reported a position in DNA in Q1 2025 and has held it in 3 quarters since. 183 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

  • Aquatic Capital Management held 4,828 shares of Ginkgo Bioworks worth $47.8K as of Q2 2026.
  • Aquatic Capital Management bought 3,002 Ginkgo Bioworks shares in Q2 2026, an estimated $25.1K.
  • Ginkgo Bioworks made up ﹤0.01% of Aquatic Capital Management's portfolio in Q2 2026, its #1155 holding.
  • Aquatic Capital Management first reported a position in Ginkgo Bioworks in Q1 2025 and has held it in 3 quarters since.
  • 183 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.